Retrophin, INC.
Biopharmaceutical Company
Based in CA
🤖
AI Overview
With $140K in lobbying spend across 8 quarterly filings, Retrophin, INC is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2019 to 2020.
$140K
Total Spend
2
Years Active
1
Firms Hired
1
Lobbyists Deployed
2
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2019 | $80K |
| 2020 | $60K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Pharmacy
- •General issues related to the Orphan Drug Act, drug pricing, rare diseases, and patient/caregiver assistance
- •General issues related to rare disease and patient care
- •General issues related to the CREATES Act, the Orphan Drug Act, and drug pricing
- •S.340 - CREATES Act of 2019
- •The Orphan Drug Act
- •Drug pricing
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.